ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Consumer Products

BASF, Glycosyn join for HMOs for adults

by Melody M. Bomgardner
May 25, 2019 | APPEARED IN VOLUME 97, ISSUE 21

 

09721-buscon12-fucosyl.jpg

BASF and Glycosyn will partner to develop human milk oligosaccharides for use in dietary supplements, functional nutrition, and medical food. Manufacturing of HMOs such as 2′-fucosyllactose was launched as a way to make infant formula more like mother’s milk. But now firms want to add the sugars to products promising to improve gastrointestinal health in adolescents and adults. Glycosyn has patents for those HMO uses, while BASF brings manufacturing expertise.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment